TY - JOUR
AR - ACO-2018-1-102
TI - Serum carcinoembryonic antigen (CEA) levels are associated with the decrease/loss of p27 immunohistochemical expression in non-small cell lung cancer
AU -  I. , Abdukader
AU -  Mª , Pombo
AU -  S. Rodriguez-, Segade
AU - Alvaro , Ruibal
AU - F. , Gude
AU - Michel , Herranz
AU - P, Aguiar
JO - Annals of Clinical Oncology
PY - 2018
DA - Tue 16, Oct 2018
SN - 2674-3248
DO - http://dx.doi.org/10.31487/j.ACO.2018.01.002
UR - https://www.sciencerepository.org/serum-carcinoembryonic-antigen-CEA-levels-are-associated-with-the-decrease-loss-of-p27-immunohistochemical-expression-in-non-small-cell-lung-cancer_ACO-1-102 
KW - Non-small cell lung cancer (NSCLC), p27, carcinoembryonic antigen, CEA
AB - Objective: to study the possible relation between immunohistochemical expression of p27 and serum
carcinoembryonic antigen (CEA) levels in patients with non-small cell lung cancer (NSCLC)
Material and Methods: The study group included 35 patients with NSCLC (15 squamous and 20
adenocarcinomas). Immunohistochemical expression of p27 was studied through the technique of tissuematrix using Tissue Arrayer Device, with monoclonal antibody M-T247 (Dako. Denmark). CEA serum
levels were assayed using the “ECLIA” from Roche (Swiss).
Results: P27 expression was noted in 27 cases (77,1%), being slightly (+) in 14 cases and strong (++) in 13
cases. CEA serum levels were higher (p:0,026) in + positive carcinomas (range: 2,2-570,7; median 7,6
ng/ml) than in ++ positive carcinoma (range: 1,5-35,1; median 2,7), but there were not differences between
+ positive and negative carcinomas. Likewise, there were statistically significant differences (p:0,043)
between ++ positive group and -/+ group (r:0,8-766,7; median 6,3 ng/ml).
Conclusions: Our results, preliminary do to the reduced number of patients included in the study, suggest
that in patients with NSCLC, serum carcinoembryonic antigen levels can be associated with the
decrease/loss of p27 immunohistochemical expression, important biological feature observed in various
tumors, included lung carcinomas.